Milestone Pharmaceuticals (MIST) Operating Leases (2019 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Operating Leases came in at $366000.0 in Q1 2026, down 51.72% YoY from $758000.0 in Q1 2025, and down 32.1% on a QoQ basis from $539000.0 in Q4 2025.
Milestone Pharmaceuticals (MIST) Operating Leases (2019 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 8 years of Operating Leases data on file, last reported at $366000.0 in Q1 2026.
- Quarterly Operating Leases fell 51.72% year-over-year to $366000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $366000.0 (down 51.72% YoY) and the FY2025 annual result came in at $539000.0, down 38.33% from the prior year.
- Operating Leases slipped to $366000.0 in Q1 2026, from $539000.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $2.1 million in Q3 2022 to a low of $366000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.0 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2023 — Operating Leases soared 350.26% — and 2026, when it sank 51.72%.
- Tracing MIST's Operating Leases over 5 years: stood at $2.0 million in 2022, then slipped by 27.0% to $1.5 million in 2023, then plunged by 40.01% to $874000.0 in 2024, then slumped by 38.33% to $539000.0 in 2025, then sank by 32.1% to $366000.0 in 2026.
- The last three Operating Leases figures came in at $366000.0 (Q1 2026), $539000.0 (Q4 2025), and $519000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 192,000.00 |
| Mar 31, 2026 | 366,000.00 |
| Dec 31, 2025 | 539,000.00 |
| Sep 30, 2025 | 519,000.00 |
| Jun 30, 2025 | 641,000.00 |
| Mar 31, 2025 | 758,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.73 Mn |
| Mar 31, 2023 | 1.86 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.09 Mn |
| Jun 30, 2022 | 384,000.00 |
| Mar 31, 2022 | 433,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 512,000.00 |